Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · Real-Time Price · USD

1.220

+0.010 (0.83%)

At close: Aug 21, 2026, 4:00 PM EDT

1.230

+0.010 (0.82%)

After-hours: Aug 21, 2026, 7:39 PM EDT

Spero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.77	40.27	52.89	76.33	109.11	112.58
Short-Term Investments	-	-	-	-	-	33.82
Cash & Short-Term Investments	50.77	40.27	52.89	76.33	109.11	146.4
Cash Growth	62.77%	-23.87%	-30.71%	-30.04%	-25.47%	15.36%
Accounts Receivable	-	25.36	49.39	49.15	-	-
Other Receivables	0.03	0.03	3.09	1.55	1.08	2.64
Receivables	0.03	25.39	52.48	50.7	1.08	2.64
Prepaid Expenses	0.79	1.63	1.91	4.18	3.38	8.83
Total Current Assets	51.58	67.29	107.28	131.21	113.57	157.87
Property, Plant & Equipment	1.03	1.48	3.11	4.16	5.49	7.56
Long-Term Accounts Receivable	-	-	-	46.59	-	-
Other Long-Term Assets	0.15	0.15	0.15	0.44	5.74	5.64
Total Assets	52.77	68.92	110.54	182.39	124.8	171.07

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.16	0.69	7.31	1.38	0.62	1.1
Accrued Expenses	6.11	5.58	17.27	6.56	8.53	14.35
Current Portion of Leases	2	1.96	1.75	1.72	1.69	1.36
Current Income Taxes Payable	0.16	0.38	0.17	0.39	-	-
Current Unearned Revenue	-	0.26	22.12	27.11	10.37	1.86
Other Current Liabilities	-	-	0.46	-	0.45	-
Total Current Liabilities	8.43	8.87	49.07	37.15	21.65	18.67
Long-Term Debt	-	-	-	-	-	48.41
Long-Term Leases	0.04	0.94	2.55	3.83	4.96	5.97
Long-Term Unearned Revenue	-	-	12.8	34.43	22.17	8.79
Other Long-Term Liabilities	0.09	0.09	-	0.09	0.1	0.94
Total Liabilities	8.56	9.9	64.42	75.5	48.87	82.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.06	0.05	0.05	0.03
Additional Paid-In Capital	511.97	510.03	505.71	497.91	489.76	455.72
Retained Earnings	-467.82	-451.07	-459.64	-391.07	-413.88	-367.46
Comprehensive Income & Other	-	-	-	-	-	-0
Total Common Equity	44.2	59.02	46.12	106.89	75.93	88.29
Shareholders' Equity	44.2	59.02	46.12	106.89	75.93	88.29
Total Liabilities & Equity	52.77	68.92	110.54	182.39	124.8	171.07

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.04	2.9	4.3	5.54	6.65	55.75
Net Cash (Debt)	48.73	37.37	48.59	70.79	102.46	90.65
Net Cash Growth	76.70%	-23.09%	-31.36%	-30.91%	13.02%	-23.86%
Net Cash Per Share	0.81	0.63	0.90	1.34	2.73	2.93
Filing Date Shares Outstanding	58.23	57.89	55.9	53.87	52.57	32.76
Total Common Shares Outstanding	58.15	56.41	54.59	53	52.46	32.39
Working Capital	43.16	58.42	58.2	94.06	91.92	139.2
Book Value Per Share	0.76	1.05	0.84	2.02	1.45	2.73
Tangible Book Value	44.2	59.02	46.12	106.89	75.93	88.29
Tangible Book Value Per Share	0.76	1.05	0.84	2.02	1.45	2.73
Machinery	-	-	-	1.55	1.55	1.76
Leasehold Improvements	-	-	-	1.64	1.64	1.64

SEC Filings: 10-K · 10-Q